Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
IBSI filed an 8-K on 3/25/25 for Reg FD and financials. No major news.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on March 25, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as GBS Inc., is incorporated in Delaware and headquartered in New York. This filing does not contain specific financial figures or material events beyond the reporting of these items.
Why It Matters
This 8-K filing indicates that Intelligent Bio Solutions Inc. is providing updates on its regulatory disclosures and financial statements to the SEC.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and financial statements, not indicating any immediate material changes or risks.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- March 25, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Intelligent Bio Solutions Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 25, 2025.
What were the previous names of Intelligent Bio Solutions Inc.?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
In which state is Intelligent Bio Solutions Inc. incorporated?
Intelligent Bio Solutions Inc. is incorporated in Delaware.
What is the principal executive office address for Intelligent Bio Solutions Inc.?
The principal executive office address is 135 West 41st Street, 5th Floor, New York, NY 10036.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).